Navigation Links
Springer signs publishing agreement with the Endocrine Society
Date:8/27/2009

Springer, one of the leading publishers in the fields of science, technology and medicine, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010. Hormonal cancers include two of the most deadly cancer subtypes, cancers of the breast and prostate. In addition to these cancers, Hormones & Cancer will include research articles covering other less-commonly occurring cancer subtypes, such as thyroid, gynecologic and pituitary cancer. The journal will help to bridge the gap between those working in the two often disconnected fields of endocrinology and cancer research.

Hormones & Cancer will be a true translational journal, including basic scientific, epidemiological and clinical research papers. Because of the inherent multidisciplinary nature of the field, it is anticipated that the journal's focus will be on all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment. Translational studies, especially those utilizing novel cancer agents selectively designed to exert their action at hormone target tissues, will also be welcomed.

Springer and The Endocrine Society have worked together to create a highly respected, international editorial board that includes many of the leaders in this interdisciplinary field. The editor-in-chief will be Jonathan Li of the Department of Pharmacology, Toxicology, and Therapeutics at Kansas University School of Medicine in Kansas City, Kansas. Board members include V. Craig Jordan, the first to discover the breast cancer prevention properties of tamoxifen, and Kate Horwitz, Distinguished Professor of Endocrinology, Metabolism, and Diabetes at the University of Colorado Denver, and Past President of The Endocrine Society.

"The timing of this journal's launch could not be better," said Kate Horwitz. "The disciplines of endocrinology and oncology have been artificially segregated for years. This is evident in factors as disparate as the divisional structure of departments of medicine and the layout of granting agency review panels. Cancers of hormone-producing organs, and of organs that are the targets of hormones, represent a large and diverse group. Hormones & Cancer will now link them."

"We are pleased to add Hormones & Cancer to The Endocrine Society's family of journals. It will create a home for this important field of research, which is a focus of many of our members, and a concern for our practitioners and their patients," commented Margaret Shupnik, Publications Core Committee Chair, The Endocrine Society.

Henk van der Rijst, Executive Vice President, Biomedical and Life Sciences at Springer, said: "Working with a prestigious society to disseminate critical information more widely is one of our core activities. Springer looks forward to a long and collaborative partnership with The Endocrine Society."

Hormones & Cancer will be published bimonthly both electronically and in print. The journal will include Cross Reference Linking, alert services, and Online First, a feature by which articles are published online before they appear in print. The journal will be available on SpringerLink.com, the world's most comprehensive collection of scientific, technological, and medical journals, books and reference works.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related medicine news :

1. Springer launches MyCopy service for eBook users
2. Springer to publish Journal of Medicine and the Person
3. Springer to publish and distribute journal for the Societe de Pathologie Exotique
4. Springer launches Cognitive Computation
5. Springer adds Journal of Neurodevelopmental Disorders to biomedical journal portfolio
6. Springer to publish the Cerebellum
7. Springer to publish new journal focusing on ethical issues in neuroscience
8. Springer to publish International Journal of Hematology
9. Springer to launch new journal in emergency medicine
10. Springer to publish new society journal in cardiology
11. Springer launches Springer Protocols
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... ... 2017 , ... Salucro, the cloud-based payment platform that has ... and provider groups, has announced that it will now offer Parasail’s payment plans ... San Francisco health-finance startup that has launched a series of tech-based products that ...
(Date:6/27/2017)... Bradley, Illinois (PRWEB) , ... June 27, 2017 , ... ... Ill. were featured in a video designed to encourage lawmakers to protect ... and National Center for Assisted Living (AHCA/NCAL), highlights the story of Chuck and Cathy ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Children’s National Health ... Hospitals rankings, with its Neonatology program ranking #1 out of more than 1500 ... named to the coveted Honor Roll, a distinction given to the top performing children’s ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/2/2017)... -- NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company focused ... positive biochemical outcomes related to more frequent hemodialysis with ... be presented at the ERA-EDTA Congress being held June ... The research was conducted by the ... Europe (KIHDNEy) Cohort team with ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: